Categories: Entertainment

NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data

NEW YORK, Sept. 26, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on September 26th

- Advertisement -
  • Stocks are mixed after investors received key economic data earlier this morning. The PCE came out today ahead of market open. Economists estimated headline PCE to show a 2.7% increase year-over-year.
  • According to the latest data, over 60% of traders anticipate we’ll see two additional interest rate cuts before the end of the year.
  • President Trump announced Thursday that new tariffs on pharmaceuticals, heavy trucks, and furniture entering the country, including a 100% tariff on patented drugs, will take effect on October 1st.

Opening Bell
Pearson (NYSE: PSO) celebrates the 25th anniversary of listing

- Advertisement -

Closing Bell
Ronald McDonald House NY celebrates National Go Gold Day

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2783031/NYSE_Market_Update_September_26.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5532574/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–wall-street-digests-august-pce-data-302568213.html

- Advertisement -
PRNW Agency

Recent Posts

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE…

9 hours ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE…

9 hours ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am…

9 hours ago

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

18 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

18 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

18 hours ago